Associate Professor;
Director, Centre for Health Interventions and Policy Evaluation Research
Tel (65) 6516 4975
Email ephwhl@nus.edu.sg
WEE Hwee Lin
Affiliation
- NUS Saw Swee Hock School of Public Health (Primary)
Research Areas
- Use of real-world data in economic evaluation of health technologies and health services
- Incorporating patient and public preferences in the design of health services and health policy
Teaching Areas
- Health Technology Assessment
- Pharmacy Practice
Academic/Professional Qualifications
- PhD (2006), National University of Singapore
- BSc (Pharm) (Hons) (2000), National University of Singapore
Awards/Honours
- HPHSR Clinician Scientist Award, National Medical Research Council Singapore, 2022
- International Society for Quality of Life Research New Investigator Award (Poster Category), 2011
- UK-Singapore Partners in Science Collaboration Award, 2012
Career History
- Research Coordinator, Department of Rheumatology & Immunology, Singapore General Hospital, 2005-2006
- Research Scientist, Department of Rheumatology & Immunology, Singapore General Hospital, 2006-2007
Administrative Leadership
- Director, Center for Health Interventions and Policy Evaluation Research, SSHSPH, NUS, 2020 – to date
Professional/Consulting Activities
- Member, National Medical Research Council Research Training Fellowship Review Panel
- Member, Science/Research Committee, Health Science Policy Council, International Society for Pharmacoeconomics and Outcomes Research
Selected Publications
- Wang Y, et al. Int J Public Health. 2022 Jul 20;67:1604958.
- Wong JZY, et al. BMC Health Serv Res. 2021 Apr 23;21(1):379.
- Chootipongchaivat S, et al. Cancer Epidemiol Biomarkers Prev. 2021 Apr;30(4):653-660.
In the News
- Here’s what we can do to keep the lid on rising premiums, The Straits Times, 10 October 2024
- Subsidies now available for cell, tissue and gene therapy products, The Straits Times, 4 September 2024
- Should MediShield Life premiums be based on lifestyle?, The Straits Times, 23 Nov 2023
- Shifting cancer care back to public hospitals is no cure, The Straits Times, 14 July 2022